Originally Posted by
penn
"It IS amazing how in todays world, a hair growth product could out sell other products that could save your life ,rather than your hair."
True, But that is what I so like about CDY, they should soon be generating strong revenue from Advangen, that can be put towards their Midkine and midkine inhibitor development, thereby in a roundabout way saving lives by saving hair. I hope they don't sell the Advangen business, as the potential realy is enormous. Just imagine if they could licence the FGF5 inhibitor to Lynx, to go in men's hair product globaly. Trouble is watching the CDY SP is enough to make an investors hair fall out. :)